For more information or confidential assistance
Call 800-306-3180

Connecticut Widow Files Pradaxa Wrongful Death Lawsuit

diane 35 blood clot risk
Carrie Thompson, a resident of Granby, Connecticut, is suing McKesson Corporation and Boehringer Ingelheim Pharmaceuticals for the wrongful death of her husband. She claims that the defendants failed to adequately warn consumers and the prescribing health care community about the risks of Pradaxa internal bleeding,... Read More

Pradaxa Death Lawsuit Added to MDL

Pradaxa FDA warning
Boehringer Ingelheim's controversial Pradaxa anticoagulant is the subject of new litigation. The plaintiff is filing the lawsuit on behalf of her deceased husband, who allegedly died as a result of using the product. The Pradaxa death lawsuit, filed on June 21, has been added to... Read More

New Pradaxa Lawsuit Added to MDL

diane 35 blood clot risk
News of more legal action related to pharmaceutical company Boehringer Ingelheim's controversial Pradaxa anticoagulant has emerged from East St. Louis, Illinois. The Pradaxa lawsuit, filed on June 17th, was added to the ongoing multidistrict litigation (MDL 2385) now underway at the U.S. District Court for... Read More

Surviving Relatives File Pradaxa Bleeding Lawsuit

Pradaxa FDA warning
Another Pradaxa bleeding lawsuit has been filed against Boehringer Ingelheim Pharmaceuticals, et al. On May 24, 2013, the surviving relatives of Rose Vicari, who are Peter G., Sarah, Kathleen, and Cheryl Vicari, filed a complaint regarding the defendants’ medication, Pradaxa, and its alleged link to... Read More

Pradaxa Gastrointestinal Bleed Lawsuit Filed in Texas

diane 35 blood clot risk
A man from Texas has filed a lawsuit against Boehringer Ingelheim, alleging their blood-thinning medication Pradaxa resulted in severe gastrointestinal bleeding. Filed on May 2nd in the U.S. District Court for the Eastern District of Texas, it's the latest Pradaxa gastrointestinal bleed lawsuit in which... Read More

History of the FDA and Pradaxa

History of Pradaxa Side Effects: FDA Safety Alerts, Warnings
Pradaxa has been the subject of several FDA safety alerts ever since Boehringer Ingelheim introduced the blood thinning medication into the market. Based on adverse event reports submitted to the FDA and results from clinical studies, patients are at risk of suffering from serious Pradaxa... Read More

New Research Points to Risks of Pradaxa Brain Hemorrhage

Pradaxa Lawsuits
Emerging research underscores the potentially fatal consequences of Pradaxa bleeding complications. The blockbuster anticoagulant was launched by drug maker Boehringer Ingelheim back in October 2010, but the lack of a Pradaxa reversal agent has resulted in hundreds of deaths among recipients, as doctors have few means to stop the... Read More